Assessing pulmonary hypertension in COPD. Is there a role for computed tomography?
- PMID: 31564854
- PMCID: PMC6732516
- DOI: 10.2147/COPD.S207363
Assessing pulmonary hypertension in COPD. Is there a role for computed tomography?
Abstract
Pulmonary hypertension (PH) is a common complication of chronic obstructive pulmonary disease (COPD) and is associated with increased morbidity and mortality. Reference standard method to diagnose PH is right heart catheterization. Several non-invasive imaging techniques have been employed in the detection of PH. Among them, computed tomography (CT) is the most commonly used for phenotyping and detecting complications of COPD. Several CT findings have also been described in patients with severe PH. Nevertheless, CT analysis is currently based on visual findings which can lead to reproducibility failure. Therefore, there is a need for quantification in order to assess objective criteria. In this review, progresses in automated analyses of CT parameters and their values in predicting PH and COPD outcomes are presented.
Keywords: COPD; computed tomography; prediction; pulmonary hypertension.
© 2019 Coste et al.
Conflict of interest statement
Professor Laurent reports personal fees from Boehringer-Ingelheim, Roche, and Chiesi, outside the submitted work. Professor Pierre-Olivier Girodet reports personal fees, non-financial support from Novartis, personal fees, non-financial support from Chiesi, personal fees, non-financial support from Boehringer-Ingelheim, personal fees, non-financial support from AstraZeneca, personal fees, non-financial support from ALK, outside the submitted work. Professor Patrick Berger reports grants from Novartis, personal fees, non-financial support from AstraZeneca, personal fees, non-financial support from Menarini, personal fees, non-financial support from Circassia, personal fees, non-financial support from Sanofi, personal fees from Teva, outside the submitted work; in addition, Prof Berger has a patent Geometric characterization of airways using MRI. 22605-FR pending. The authors report no other conflicts of interest in this work.
Figures
Similar articles
-
CT evaluation of small pulmonary vessels area in patients with COPD with severe pulmonary hypertension.Thorax. 2016 Sep;71(9):830-7. doi: 10.1136/thoraxjnl-2015-207696. Epub 2016 Apr 15. Thorax. 2016. PMID: 27084957
-
Characteristics of Chronic Obstructive Pulmonary Disease Patients with Pulmonary Hypertension Assessed by Echocardiography in a Three-Year Observational Cohort Study.Int J Chron Obstruct Pulmon Dis. 2020 Mar 3;15:487-499. doi: 10.2147/COPD.S230952. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32184586 Free PMC article.
-
Computed tomographic measurement of airway remodeling and emphysema in advanced chronic obstructive pulmonary disease. Correlation with pulmonary hypertension.Am J Respir Crit Care Med. 2015 Jan 1;191(1):63-70. doi: 10.1164/rccm.201408-1423OC. Am J Respir Crit Care Med. 2015. PMID: 25393421
-
Pulmonary hypertension secondary to chronic obstructive pulmonary disease.Rom J Intern Med. 2012 Oct-Dec;50(4):259-68. Rom J Intern Med. 2012. PMID: 23610973 Review.
-
Recent Advances in Computed Tomography Imaging in Chronic Obstructive Pulmonary Disease.Ann Am Thorac Soc. 2018 Mar;15(3):281-289. doi: 10.1513/AnnalsATS.201705-377FR. Ann Am Thorac Soc. 2018. PMID: 28812906 Free PMC article. Review.
Cited by
-
Respiratory Diaphragm Motion-Based Asynchronization and Limitation Evaluation on Chronic Obstructive Pulmonary Disease.Diagnostics (Basel). 2023 Oct 20;13(20):3261. doi: 10.3390/diagnostics13203261. Diagnostics (Basel). 2023. PMID: 37892082 Free PMC article.
-
Efficacy of computed tomography in diagnosing pulmonary hypertension: A systematic review and meta-analysis.Front Cardiovasc Med. 2022 Oct 5;9:966257. doi: 10.3389/fcvm.2022.966257. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36277788 Free PMC article.
-
Main pulmonary artery enlargement predicts 90-day readmissions in Chinese COPD patients.J Thorac Dis. 2021 Oct;13(10):5731-5740. doi: 10.21037/jtd-21-344. J Thorac Dis. 2021. PMID: 34795922 Free PMC article.
-
Predictors of residual pulmonary vascular obstruction after anticoagulation monotherapy in patients with intermediate-risk pulmonary embolism.J Thorac Dis. 2021 Jul;13(7):4217-4227. doi: 10.21037/jtd-21-403. J Thorac Dis. 2021. PMID: 34422350 Free PMC article.
-
Measuring pulmonary function in COPD using quantitative chest computed tomography analysis.Eur Respir Rev. 2021 Jul 13;30(161):210031. doi: 10.1183/16000617.0031-2021. Print 2021 Sep 30. Eur Respir Rev. 2021. PMID: 34261743 Free PMC article. Review.
References
-
- From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2018. Available from: http://www.goldcopd.org/. Accessed July31, 2009.
-
- From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2017. Available from: https://goldcopd.org. Accessed July31, 2009.
-
- Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67–119. doi:10.1093/eurheartj/ehv317 - DOI - PubMed
